Effect of pH variation on the susceptibility ofHelicobacter pylori to three macrolide antimicrobial agents and temafloxacin
- 1 February 1993
- journal article
- other
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 12 (2) , 131-133
- https://doi.org/10.1007/bf01967591
Abstract
The in vitro susceptibility of 27 clinical isolates ofHelicobacter pylori to erythromycin, clarithromycin, azithromycin and temafloxacin under various pH conditions was evaluated. Clarithromycin (MIC90 0.03 µg/ml) was found to be significantly more active than either erythromycin (MIC90 0.125 µg/ml) or azithromycin (MIC90 0.25 µg/ml) at a neutral pH. Lowering the pH to 5.75 resulted in a loss in efficacy from 8- to 32-fold for all three macrolides studied. The MIC90 of clarithromycin (0.5 µg/ml) remained lower than those of azithromycin (2 µg/ml) and erythromycin (4 µg/ml). No synergism or antagonism was observed with combinations of clarithromycin and temafloxacin at either the neutral or lower pH values.Keywords
This publication has 15 references indexed in Scilit:
- Clarithromycin and omeprazole for Helicobacter pyloriThe Lancet, 1992
- The Susceptibility of Campylobacter pylori to Antiulcer Agents and AntibioticsJournal of Clinical Gastroenterology, 1990
- Effect of varying pH on the susceptibility ofCampylobacter pylori to antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosaJournal of Antimicrobial Chemotherapy, 1988
- Susceptibility of Campylobacter pylori to macrolides and fluoroquinolonesJournal of Antimicrobial Chemotherapy, 1988
- Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomachJournal of Antimicrobial Chemotherapy, 1988
- The Role of Antibiotics inCampylobacter pyloriAssociated Peptic Ulcer DiseaseScandinavian Journal of Gastroenterology, 1988
- Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.BMJ, 1986
- Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampinAntimicrobial Agents and Chemotherapy, 1986
- Spiral organisms in endoscopic biopsies of the human stomach.Journal of Clinical Pathology, 1984